• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质基质细胞与机器灌注的联合使用是实体器官移植中器官保存的一种新策略。

Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation.

机构信息

Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.

Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.

出版信息

Cell Tissue Res. 2021 Apr;384(1):13-23. doi: 10.1007/s00441-020-03406-3. Epub 2021 Jan 13.

DOI:10.1007/s00441-020-03406-3
PMID:33439348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016762/
Abstract

Organ preservation is a prerequisite for an urgent increase in the availability of organs for solid organ transplantation (SOT). An increasing amount of expanded criteria donor (ECD) organs are used clinically. Currently, the paradigm of organ preservation is shifting from simple reduction of cellular metabolic activity to maximal simulation of an ex vivo physiological microenvironment. An ideal organ preservation technique should not only preserve isolated organs but also offer the possibility of rehabilitation and evaluation of organ function prior to transplantation. Based on the fact that mesenchymal stromal cells (MSCs) possess strong regeneration properties, the combination of MSCs with machine perfusion (MP) is expected to be superior to conventional preservation methods. In recent years, several studies have attempted to use this strategy for SOT showing promising outcomes. With better organ function during ex vivo preservation and the potential of utilization of organs previously deemed untransplantable, this strategy is meaningful for patients with organ failure to help overcome organ shortage in the field of SOT.

摘要

器官保存是增加用于实体器官移植 (SOT) 的器官可用性的前提条件。越来越多的扩展标准供体 (ECD) 器官被临床使用。目前,器官保存的模式正在从简单地降低细胞代谢活性转变为最大限度地模拟体外生理微环境。理想的器官保存技术不仅应能保存分离的器官,而且还应能在移植前提供器官功能康复和评估的可能性。基于间充质基质细胞 (MSCs) 具有强大的再生特性这一事实,预计将 MSCs 与机器灌注 (MP) 相结合将优于传统的保存方法。近年来,多项研究试图将该策略用于 SOT,结果令人鼓舞。这种策略具有意义,因为它可以改善器官在体外保存期间的功能,并且有可能利用以前被认为不可移植的器官,这有助于解决 SOT 领域的器官短缺问题,帮助器官衰竭患者克服器官短缺问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/8016762/5851f53a3893/441_2020_3406_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/8016762/e9d575c64f8b/441_2020_3406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/8016762/5851f53a3893/441_2020_3406_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/8016762/e9d575c64f8b/441_2020_3406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/8016762/5851f53a3893/441_2020_3406_Fig2_HTML.jpg

相似文献

1
Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation.间质基质细胞与机器灌注的联合使用是实体器官移植中器官保存的一种新策略。
Cell Tissue Res. 2021 Apr;384(1):13-23. doi: 10.1007/s00441-020-03406-3. Epub 2021 Jan 13.
2
Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs.体外间充质干细胞疗法用于再生机器灌注器官。
Int J Mol Sci. 2021 May 15;22(10):5233. doi: 10.3390/ijms22105233.
3
Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.边缘器官在现代机器灌注和先进器官监测时代的移植。
Front Immunol. 2020 May 12;11:631. doi: 10.3389/fimmu.2020.00631. eCollection 2020.
4
Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation.间质干细胞在机器灌注中的应用:器官保存的新兴新策略。
Front Immunol. 2021 Dec 22;12:713920. doi: 10.3389/fimmu.2021.713920. eCollection 2021.
5
Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells?机器灌注在器官移植中的应用:一种用间充质干细胞对供体移植物进行体外预处理的工具?
Curr Opin Organ Transplant. 2013 Feb;18(1):24-33. doi: 10.1097/MOT.0b013e32835c494f.
6
[Machine perfusion in transplantation surgery].[移植手术中的机器灌注]
Chirurgie (Heidelb). 2024 Aug;95(8):610-617. doi: 10.1007/s00104-024-02122-w. Epub 2024 Jul 25.
7
Mesenchymal Stem Cell Utilization for In Vitro Donor Liver Machine Perfusion Preservation: Current Status and Future Directions.间质干细胞在体外供肝机器灌注保存中的应用:现状与未来方向。
Stem Cells Transl Med. 2023 Oct 5;12(10):665-675. doi: 10.1093/stcltm/szad053.
8
Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects.机器灌注延长标准供体器官:免疫方面。
Front Immunol. 2020 Feb 27;11:192. doi: 10.3389/fimmu.2020.00192. eCollection 2020.
9
Organ Repair and Regeneration During Dynamic Preservation: The Future is Nano.动态保存过程中的器官修复和再生:未来是纳米的。
Transpl Int. 2023 Nov 10;36:11947. doi: 10.3389/ti.2023.11947. eCollection 2023.
10
Machine perfusion organ preservation: Highlights from the American Transplant Congress 2021.机器灌注器官保存:2021 年美国移植大会亮点。
Artif Organs. 2022 Feb;46(2):315-320. doi: 10.1111/aor.14100. Epub 2021 Nov 9.

引用本文的文献

1
De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells.在经新生儿肾干/祖细胞处理的人类肾脏中,SIX2 被从头激活。
Am J Transplant. 2022 Dec;22(12):2791-2803. doi: 10.1111/ajt.17164. Epub 2022 Aug 11.
2
Organ Bioluminescence Imaging Under Machine Perfusion Setting for Assessing Quality of Harvested Organ Preservation.器官在机器灌流条件下的生物发光成像,用于评估器官采集保存质量。
Methods Mol Biol. 2022;2525:309-320. doi: 10.1007/978-1-0716-2473-9_24.

本文引用的文献

1
[Postoperative complications and long-term outcomes of transplantation with expended criteria donors transplants].[边缘供体移植术后并发症及长期预后]
Prog Urol. 2020 Oct;30(12):655-662. doi: 10.1016/j.purol.2020.04.019. Epub 2020 Aug 16.
2
Treating Ischemically Damaged Porcine Kidneys with Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells During Ex Vivo Normothermic Machine Perfusion.在体外常温机器灌注期间用人骨髓和脂肪组织来源的间充质基质细胞治疗缺血性损伤的猪肾。
Stem Cells Dev. 2020 Oct 15;29(20):1320-1330. doi: 10.1089/scd.2020.0024. Epub 2020 Sep 2.
3
Heme oxygenase-1-modified bone marrow mesenchymal stem cells combined with normothermic machine perfusion to protect donation after circulatory death liver grafts.
血红素加氧酶-1 修饰的骨髓间充质干细胞联合常温机械灌注保护脑死亡供肝。
Stem Cell Res Ther. 2020 Jun 5;11(1):218. doi: 10.1186/s13287-020-01736-1.
4
Bone marrow mesenchymal stem cells combine with normothermic machine perfusion to improve rat donor liver quality-the important role of hepatic microcirculation in donation after circulatory death.骨髓间充质干细胞与常温机械灌注相结合,改善大鼠供体肝质量-在停循环死亡后供肝中的肝微循环的重要作用。
Cell Tissue Res. 2020 Aug;381(2):239-254. doi: 10.1007/s00441-020-03202-z. Epub 2020 Apr 29.
5
Potential application of an injectable hydrogel scaffold loaded with mesenchymal stem cells for treating traumatic brain injury.负载间充质干细胞的可注射水凝胶支架在治疗创伤性脑损伤中的潜在应用。
J Mater Chem B. 2018 May 21;6(19):2982-2992. doi: 10.1039/c7tb03213g. Epub 2018 Apr 25.
6
Normothermic Machine Perfusion Combined with Bone Marrow Mesenchymal Stem Cells Improves the Oxidative Stress Response and Mitochondrial Function in Rat Donation After Circulatory Death Livers.常温机器灌注联合骨髓间充质干细胞改善循环死亡供肝大鼠的氧化应激反应和线粒体功能。
Stem Cells Dev. 2020 Jul 1;29(13):835-852. doi: 10.1089/scd.2019.0301. Epub 2020 May 5.
7
OPTN/SRTR 2018 Annual Data Report: Kidney.OPTN/SRTR 2018 年度数据报告:肾脏。
Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672.
8
[Effects of bone marrow mesenchymal stem cells combined with normothermic mechanical perfusion on biliary epithelial cells donated after cardiac death in rats].[骨髓间充质干细胞联合常温机械灌注对大鼠心脏死亡后捐献的胆管上皮细胞的影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Sep;31(9):1137-1142. doi: 10.3760/cma.j.issn.2095-4352.2019.09.016.
9
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.用于 deceased 供体肾移植的机器灌注保存与静态冷藏比较
Cochrane Database Syst Rev. 2019 Mar 15;3(3):CD011671. doi: 10.1002/14651858.CD011671.pub2.
10
Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment.间充质干细胞通过抑制中性粒细胞募集来减轻肝缺血/再灌注损伤。
J Immunol Res. 2018 Dec 3;2018:7283703. doi: 10.1155/2018/7283703. eCollection 2018.